2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Neehar Parikh, MD, discusses the importance of multidisciplinary care in the treatment of patients with hepatocellular carcinoma.
Neehar Parikh, MD, medical director, Multidisciplinary Liver Tumor Clinic, Living Donor Liver Transplantation Program, assistant professor, Michigan Medicine, University of Michigan, discusses the importance of multidisciplinary care in the treatment of patients with hepatocellular carcinoma (HCC).
Patients with HCC are commonly treated by a multidisciplinary team in the university setting, says Parikh. These groups consist of hepatologists, interventional radiologists, oncologists, diagnostic radiologists, and palliative care specialists, says Parikh.
These teams work as a single unit to optimize treatment for patients and address any complications that arise, says Parikh.
Importantly, analyses suggest that there is a survival advantage when patients who receive curative intent therapy are treated by a multidisciplinary team compared with those treated by a single physician, concludes Parikh.
Related Content: